Medicure, Inc. is a pharmaceutical company, which engages in the research, clinical development, and commercialization of cardiovascular therapeutics. The company is headquartered in Winnipeg, Manitoba and currently employs 23 full-time employees. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. The company operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. The company operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. The company develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Based on 8 analysts giving stock ratings to MCUJF, updated on Dec 01, 2021
Sell
Strong buy
0
Buy
0
Hold
3
Sell
2
Strong sell
3
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for MCUJF. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: MCUJF is a Sell candidate.
MCUJF stock price ended at $0.8 on Thursday, after dropping 1.23%
On the latest trading day Mar 05, 2026, the stock price of MCUJF fell by 1.23%, dropping from $0.80 to $0.80. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.80 and a high of $0.80. On the latest trading day, the trading volume for MCUJF decreased by 15.2K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 1.0K shares were traded, with a market value of approximately $8.3M.
MCUJF Technical Signals
Technical Signals Summary
Buy Signals 2
Neutral Signals 2
Sell Signals 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
MCUJF currently exhibits 2 buy signals and 3 sell signals. The stock has been in an downtrend since 12:00 AM, with a total price change of -11.11% during this period. Overall, the technical indicators point to a Sell outlook for the mid-term.
Bullish/Bearish Signals for MCUJF
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for MCUJF. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to MCUJF?
According to technical analysis, Medicure Inc has an aggregate signal of Sell. Medicure Inc has 2 Buy signals, 2 Neutral Signals and 3 sell signals.
What are the Fibonacci retracement levels for MCUJF?
The Fibonacci retracement level for Medicure Inc is between 61.8% and 78.6%
What is the RSI for Medicure Inc?
The RSI for Medicure Inc is currently 42.34, indicating a neutral condition
What is Medicure Inc price for the next 12 months?
Medicure Inc MCUJF price for the next 12 months is estimated at $0.
How high is Medicure Inc expected to go?
According to wall street analysts, Medicure Inc is expected to reach a high forecast of $0.